Market Currents
Cambrex (CBM +25.6%) shares are soaring the day after the maker of pharmaceutical ingredients...
-
Wednesday, August 3, 2011, 1:22 PM ETCambrex (CBM +25.6%) shares are soaring the day after the maker of pharmaceutical ingredients reported better-than-expected Q2 earnings and revenue. Cambrex said sales rose 17.6% Y/Y to $65.7M; excluding the impact of a weak U.S. dollar, sales rose 6.9%.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
